Overview

Rolf M. Zinkernagel (born January 6, 1944) is a Swiss physician and researcher whose work transformed cellular immunology. Trained in medicine and experimental biology, he built a career investigating how the body recognizes and eliminates virus‑infected cells. He is associated with the University of Zurich and is widely cited for fundamental discoveries about T lymphocytes and antigen recognition.

Major discovery

In collaboration with Peter C. Doherty, Zinkernagel demonstrated that cytotoxic T cells detect infected cells only when small antigenic fragments are presented in the context of the host's own major histocompatibility complex (MHC). This concept, often referred to as MHC restriction, clarified why immune responses are specific to both the pathogen and the infected individual's genetic background. Their work explained key observations in transplant rejection, viral immunity, and the design of peptide‑based vaccines.

Career and honors

Zinkernagel has held research and teaching posts in Europe and Australia and has been recognized by scientific academies for his contributions. He holds distinctions such as FAA and honors including the Australian order designation shown as AC in some listings. His laboratory studies combined virology, immunology and animal models to reveal how adaptive immunity operates at the cellular level.

Impact and applications

The recognition of peptide‑MHC presentation reshaped multiple fields: vaccine research now considers peptide epitopes and MHC diversity; tumor immunology uses similar principles to identify cancer neoantigens; and diagnostic assays for cellular immunity rely on T cell recognition patterns. Zinkernagel's findings remain foundational to modern immunotherapy and infectious disease research.

Notable facts and legacy

  • Zinkernagel is a native of Switzerland and trained in clinical medicine before turning to laboratory research in immunology.
  • He shared the 1996 Nobel Prize in Physiology or Medicine for the discovery of how the immune system recognizes virus‑infected cells.
  • His collaboration with Doherty exemplifies how carefully designed animal experiments can reveal general principles of immune recognition.

For further reading about Zinkernagel's methods, selected publications and the historical context of the discovery, consult institutional pages and reviews that summarize the development and consequences of MHC‑restricted T cell recognition.